VSee Health, Inc. (VSEEW) Aandelenanalyse

Bedrijfsoverzicht

VSee Health, Inc. is a provider of telehealth care solutions operating primarily within the United States, utilizing its iDoc Telehealth platform to treat and coordinate care for acutely ill patients in neurointensive care, cardiac intensive care, and intensive care units for conditions such as stroke, spinal cord injury, brain trauma, and other critical health issues. The company operates within the N/A sector and N/A industry classifications, indicating a specialized niche within the broader healthcare technology landscape that may not yet be fully consolidated into standard industry categorizations. In terms of scale, the company reports a market cap listed as N/A, an annual revenue of $14.62 million, and an employee count that is not publicly disclosed in the available data. These financial metrics suggest that VSee Health functions as a small-cap or micro-cap entity with limited public market capitalization relative to large-cap peers, while the revenue figure of $14.62 million indicates a modest operational footprint that serves a specific, high-acuity patient population rather than a mass-market consumer base.

Financiële gezondheid

The company reported a revenue of $14.62 million over the trailing twelve months, yet it simultaneously recorded a net income of $-14,712,850 and an EBITDA of $-6,995,337, revealing a significant divergence between top-line generation and bottom-line profitability that points to a cost structure heavily weighted by expenses exceeding revenues. This substantial gap between the $14.62 million in revenue and the negative net income indicates that operating costs, likely driven by high fixed costs in medical technology development or specialized staffing, are consuming the entire revenue stream and generating losses. Free cash flow stands at $-967,435, which signifies that the company is burning cash from its operations and investing activities combined, thereby limiting its current financial flexibility and reliance on external capital sources to fund ongoing activities. When analyzing profitability efficiency, the gross margin sits at 50.3%, suggesting that the core delivery of telehealth services retains a healthy portion of revenue after direct costs, whereas the operating margin of -87.6% and profit margin of -100.6% illustrate that general and administrative expenses are disproportionately high, erasing all gross profit before reaching the bottom line. The balance sheet presents a leveraged position with total cash of $5.27 million against total debt of $3.26 million, supported by a debt-to-equity ratio of 59.78, indicating that while debt levels are present, they are partially offset by cash reserves though equity is significantly diluted by losses. Liquidity constraints are evident with a current ratio of 0.52, which implies that the company's current assets are insufficient to cover its current liabilities without generating additional operating cash or securing further financing. Furthermore, the return on equity of -541.5% and return on assets of -28.2% demonstrate that management effectiveness in generating returns on invested capital is severely compromised by the persistent net losses and the erosion of shareholder value over the reporting period.

Waarderingsbeoordeling

Valuation metrics for VSee Health, Inc. include a trailing P/E ratio and forward P/E ratio both listed as N/A, reflecting the inability to value the stock based on earnings multiples due to the absence of positive earnings, which implies that traditional earnings-based valuation models are not applicable to this entity. The price-to-book ratio is recorded at -0.13, a figure that typically indicates a negative book value per share or significant impairment, suggesting the market prices the company well below its accounting book value or that the book value is technically negative due to accumulated deficits. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also listed as N/A, further reinforcing that the company cannot be valued using standard multiples due to its lack of profitability and potentially undefined enterprise value relative to earnings. Regarding trading range, the 52-week high and low are both recorded at $0.04, meaning the stock is currently trading at 0% below the 52-week high and 0% above the 52-week low, indicating a lack of price momentum or volatility within the reporting year. The beta value is 0.65, which suggests that the stock's price volatility is lower than the broader market, moving at roughly 35% less than the market average, a characteristic often seen in small-cap or low-volume stocks that may not correlate strongly with major market indices.

Growth & Income

VSee Health, Inc. has achieved a revenue growth rate of 5.1% year-over-year, while earnings growth is listed as N/A due to the company's continued unprofitability, indicating that top-line expansion is occurring in the absence of earnings accretion rather than through a trajectory of growing profitability. As a non-dividend payer, the company does not distribute a dividend yield or utilize a payout ratio, which implies that all available cash flow is retained internally to support operations, debt repayment, or potential future growth initiatives rather than being distributed to shareholders. The overall growth and income profile is characterized by positive revenue expansion coupled with persistent operational losses and no dividend distribution, highlighting a growth-at-any-cost strategy that prioritizes market share or service expansion over immediate financial returns or shareholder yield.